These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6409615

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Superficial bladder cancer: prophylaxis of recurrence and progression].
    Miyanaga N, Akaza H, Koiso K.
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
    [Abstract] [Full Text] [Related]

  • 8. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J, Bouffier B, Etievent JP, Bittard M.
    J Urol (Paris); 1983 Nov; 89(2):85-9. PubMed ID: 6408192
    [Abstract] [Full Text] [Related]

  • 9. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ, Dean AL, Uson AC, Roberts M, Longo F.
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract] [Full Text] [Related]

  • 10. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH.
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D, Blackard C.
    Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravesical 4'-epi-doxorubicin (epirubicin) versus bacillus Calmette-Guérin. A controlled prospective study on the prophylaxis of superficial bladder cancer.
    Melekos MD, Chionis HS, Paranychianakis GS, Dauaher HH.
    Cancer; 1993 Sep 01; 72(5):1749-55. PubMed ID: 8348504
    [Abstract] [Full Text] [Related]

  • 17. Does intravesical chemotherapy prevent invasive bladder cancer?
    Green DF, Robinson MR, Glashan R, Newling D, Dalesio O, Smith PH.
    J Urol; 1984 Jan 01; 131(1):33-5. PubMed ID: 6418897
    [Abstract] [Full Text] [Related]

  • 18. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R, Reina GR, Hontoria JM, Merino C, Olivier C, Carballido J.
    Actas Urol Esp; 1989 Jan 01; 13(1):19-23. PubMed ID: 2496583
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of implantation of murine bladder tumor by thiotepa in cauterized bladder.
    Pan JS, Slocum HK, Rustum YM, Greco WR, Gaeta JF, Huben RP.
    J Urol; 1989 Dec 01; 142(6):1589-93. PubMed ID: 2511340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.